It’s getting cold in here! PCI expands cold chain capacity in Philadelphia

Pharmaceutical outsourcing services provider, PCI Pharma Services, has revealed it will be expanding its onsite cold chain storage capacity by 60% at its site in Philadelphia, Pennsylvania.

The investment is set to include an additional 500 pallet spaces, which increases its onsite 2–8°C refrigerated storage at its commercial packaging centre of excellence to more than 1,300 pallets.

“It has been estimated Biologics represent more than 37% of all drugs in pipeline development,” states Ken Richardson, PCI vice president of Global Engineering. “That certainly mirrors the trends we are seeing towards growth in parenteral delivery forms and medicines requiring strict end-to-end cold chain logistics. On average, we launch over 50 products a year and a large proportion of those are drugs with needs for end-to-end cold chain. We continue to invest considerably in both areas — adding infrastructure to meet growing demand for vial labelling, syringe labelling and assembly, as well as labelling and assembly of autoinjectors and pens, complemented by investing in ample site storage for these medicines needing refrigerated or frozen conditions. We anticipate these needs will increase considerably as these pipeline medicines reach commercialisation, in addition to anticipated growth associated with development of biosimilars. PCI is well positioned to support clients in both areas.”